We are live on
!
Find out more
SAM
Strategy Asset Managers Portfolio holdings
AUM
$650M
Turnover
21.36%
1-Year Est. Return
25.51%
This Fund
S&P 500
This Quarter
Est. Return
+4.34%
1 Year Est. Return
+25.51%
3 Year Est. Return
+115.5%
5 Year Est. Return
+130.94%
10 Year Est. Return
+375.79%
AUM
$470M
AUM Growth
+$5.01M
(+1.1%)
Cap. Flow
-$11.1M
Cap. Flow
% of AUM
-2.37%
Top 10 Holdings %
Top 10 Hldgs %
29.37%
Holding
143
New
13
Increased
28
Reduced
66
Closed
13
Avg Time Held
0.8
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$9.08M |
| 2 |
Devon Energy
DVN
|
+$3.01M |
| 3 |
Marriott International
MAR
|
+$2.91M |
| 4 |
NRG Energy
NRG
|
+$2.83M |
| 5 |
Vornado Realty Trust
VNO
|
+$2.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$11M |
| 2 |
Hershey
HSY
|
+$3.06M |
| 3 |
Amgen
AMGN
|
+$3.02M |
| 4 |
Newell Brands
NWL
|
+$2.88M |
| 5 |
CELG
Celgene Corp
CELG
|
+$2.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.48% |
| 2 | Healthcare | 18.58% |
| 3 | Technology | 12.68% |
| 4 | Energy | 12.56% |
| 5 | Industrials | 11.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$610B
| $14.8M | 3.16% |
141,799
-3,592
| -2% | -$363K |
2013 Q2
4 quarters
|
|
2
CVS Health
CVS
$118B
| $14.4M | 3.07% |
191,557
-8,392
| -4% | -$634K |
2013 Q2
4 quarters
|
|
3
Lockheed Martin
LMT
$123B
| $14.3M | 3.05% |
89,274
-4,264
| -5% | -$693K |
2013 Q2
4 quarters
|
|
4
DuPont de Nemours
DD
$17.8B
| $14.3M | 3.05% |
109,912
-1,500
| -1% | -$191K |
2013 Q4
2 quarters
|
|
5
Comcast
CMCSA
$77.3B
| $14.2M | 3.02% |
529,304
-13,442
| -2% | -$345K |
2013 Q2
4 quarters
|
|
6
American Express
AXP
$212B
| $14.2M | 3.02% |
149,584
-5,264
| -3% | -$475K |
2013 Q2
4 quarters
|
|
|
BHI
7
DELISTED
Baker Hughes
BHI
| $14.2M | 3.01% |
190,140
+35,727
| +23% | +$2.49M |
2013 Q2
4 quarters
|
|
8
Honeywell
HON
$66.7B
| $13.1M | 2.78% |
156,288
-2,968
| -2% | -$248K |
2013 Q2
4 quarters
|
|
9
Travelers Companies
TRV
$80.1B
| $13M | 2.77% |
138,474
-2,300
| -2% | -$210K |
2013 Q2
4 quarters
|
|
10
Walt Disney
DIS
$191B
| $11.4M | 2.42% |
132,813
-6,140
| -4% | -$501K |
2013 Q2
4 quarters
|
|
11
Microsoft
MSFT
$4.01T
| $11.1M | 2.37% |
266,640
-3,730
| -1% | -$151K |
2013 Q2
4 quarters
|
|
12
Merck
MRK
$358B
| $10.9M | 2.31% |
196,801
-3,960
| -2% | -$216K |
2013 Q2
4 quarters
|
|
13
Royal Bank of Canada
RY
$272B
| $10.6M | 2.27% |
148,994
-521
| -0.3% | -$35.3K |
2013 Q3
3 quarters
|
|
|
RDS.A
14
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $10.6M | 2.27% |
138,304
-1,703
| -1% | -$124K |
2013 Q2
4 quarters
|
|
15
Oracle
ORCL
$408B
| $10.5M | 2.23% |
258,054
-5,312
| -2% | -$219K |
2013 Q2
4 quarters
|
|
16
Fluor
FLR
$6.38B
| $10.1M | 2.14% |
130,914
-1,412
| -1% | -$108K |
2013 Q2
4 quarters
|
|
|
17
Bristol-Myers Squibb
BMY
$124B
| $9.94M | 2.12% |
204,857
+184,340
| +898% | +$9.08M |
2013 Q2
4 quarters
|
|
18
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
| $9.86M | 2.1% |
188,164
-2,347
| -1% | -$120K |
2013 Q2
4 quarters
|
|
19
JPMorgan Chase
JPM
$891B
| $9.85M | 2.1% |
170,998
-45,574
| -21% | -$2.56M |
2013 Q2
4 quarters
|
|
20
American International
AIG
$41.4B
| $9.83M | 2.09% |
180,113
+759
| +0.4% | +$40.2K |
2014 Q1
1 quarter
|
|
21
DELISTED
Seadrill Limited Common Stock
SDRL
| $9.35M | 1.99% |
874
+23
| +3% | +$225K |
2013 Q2
4 quarters
|
|
22
Procter & Gamble
PG
$365B
| $9.1M | 1.94% |
115,742
+181
| +0.2% | +$14.6K |
2013 Q2
4 quarters
|
|
23
Cisco
CSCO
$433B
| $8.96M | 1.91% |
360,385
+2,989
| +0.8% | +$71.2K |
2013 Q2
4 quarters
|
|
24
DELISTED
EMC CORPORATION
EMC
| $8.72M | 1.86% |
331,198
-2,187
| -0.7% | -$57.8K |
2013 Q2
4 quarters
|
|
25
Loews
L
$22.2B
| $8.62M | 1.84% |
195,943
+2,751
| +1% | +$120K |
2013 Q2
4 quarters
|
|
Similar funds
BI
GCM
GWAG
BRIM
PPW
OCAM
AAS
TAWM
Strategy Asset Managers's Q2 2014 Portfolio in Review
As of Q2 2014, Strategy Asset Managers held 143 positions worth $470M, up 1.1% from $465M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Strategy Asset Managers's Q2 2014 filing shows 13 new, 28 increased, 66 reduced and 13 closed positions. Its largest new stake was Devon Energy: 41,364 shares worth $3.28M. The largest sale was Boeing, an estimated $11M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Technology.
- Strategy Asset Managers's largest Q2 2014 buy was Devon Energy: 41,364 shares worth $3.28M.
- Strategy Asset Managers added most to Bristol-Myers Squibb in Q2 2014, an estimated $9.08M increase.
- Strategy Asset Managers's biggest Q2 2014 reduction was Boeing, cutting an estimated $11M.
- Strategy Asset Managers fully exited Amgen in Q2 2014, selling an estimated $3.02M.
- Strategy Asset Managers's ten largest holdings make up 29% of its $470M portfolio in Q2 2014.
- Strategy Asset Managers opened 13 new positions and closed 13 in Q2 2014.
- Strategy Asset Managers's portfolio value rose 1.1% quarter-over-quarter to $470M.
Based on Strategy Asset Managers's 13F filing for Q2 2014, filed 8 Aug 2014.